SEGLUROMET 7.5 mg/1 (Ertugliflozin and Metformin Hydrochloride TABLET, FILM COATED) 7.5 mg/1

Segluromet 7.5 mg/1 combines ertugliflozin and metformin hydrochloride for managing type 2 diabetes. This oral medication supports blood sugar control as part of a comprehensive treatment plan.

Strength

7.5 mg/1

Pack Size

500 TABLET, FILM COATED in 1 BOTTLE (0006-5374-07)

Manufacturer / TM Owner

Merck Sharp & Dohme LLC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Segluromet 7.5 mg/1 is primarily used for managing type 2 diabetes in adults. It works by combining two active ingredients, ertugliflozin and metformin hydrochloride, to help regulate blood sugar levels. This medication is often prescribed alongside diet and exercise to improve glycemic control. People often ask, 'What is Segluromet used for?' and the answer is that it is designed to assist in the management of type 2 diabetes.

Side Effects

Common effects of Segluromet 7.5 mg/1 may include symptoms such as nausea, diarrhea, and headache. Some users might experience urinary tract infections or low blood sugar. These effects can vary among individuals and are not exhaustive.

Precautions & Warnings

Segluromet 7.5 mg/1 should be handled with care. It is important to follow the advice of a healthcare provider regarding its use, especially for those with kidney issues or a history of lactic acidosis. Always store the medication as directed and keep it out of reach of children.

Avoid Interactions

Segluromet 7.5 mg/1 may interact with certain medications, including diuretics, corticosteroids, and some blood pressure drugs. Alcohol consumption should be avoided as it can increase the risk of lactic acidosis. Always inform your healthcare provider about all medications you are taking.

Frequently Asked Questions

Segluromet 7.5 mg/1 is used to manage type 2 diabetes in adults by helping to control blood sugar levels.

Segluromet 7.5 mg/1 is taken orally, typically once daily, as directed by a healthcare provider.

Common side effects may include nausea, diarrhea, headache, and urinary tract infections.

Segluromet 7.5 mg/1 may interact with certain medications, so it is important to consult a healthcare provider before combining it with other drugs.

Segluromet 7.5 mg/1 is not suitable for everyone, especially those with severe kidney problems or a history of lactic acidosis.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.